Back to Search
Start Over
Reply to 'A strong message is needed to address the issue of HCC recurrence after DAA therapy'
- Source :
- Journal of Hepatology, Journal of Hepatology, Elsevier, 2016, 65 (6), pp.1269-1270. ⟨10.1016/j.jhep.2016.07.030⟩, Journal of Hepatology, 2016, 65 (6), pp.1269-1270. ⟨10.1016/j.jhep.2016.07.030⟩
- Publication Year :
- 2016
- Publisher :
- HAL CCSD, 2016.
-
Abstract
- International audience
- Subjects :
- medicine.medical_specialty
Carcinoma, Hepatocellular
Hepatology
business.industry
Liver Neoplasms
Alternative medicine
[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology
Antiviral Agents
3. Good health
03 medical and health sciences
0302 clinical medicine
030220 oncology & carcinogenesis
Humans
Medicine
030211 gastroenterology & hepatology
Neoplasm Recurrence, Local
business
Intensive care medicine
ComputingMilieux_MISCELLANEOUS
Subjects
Details
- Language :
- English
- ISSN :
- 01688278 and 16000641
- Database :
- OpenAIRE
- Journal :
- Journal of Hepatology, Journal of Hepatology, Elsevier, 2016, 65 (6), pp.1269-1270. ⟨10.1016/j.jhep.2016.07.030⟩, Journal of Hepatology, 2016, 65 (6), pp.1269-1270. ⟨10.1016/j.jhep.2016.07.030⟩
- Accession number :
- edsair.doi.dedup.....37893a650e9154a6d266a2b5c8cbb91b
- Full Text :
- https://doi.org/10.1016/j.jhep.2016.07.030⟩